5,132,200
Participants
Start Date
July 15, 2018
Primary Completion Date
December 31, 2018
Study Completion Date
December 31, 2018
No Intervention
This study is the development of algorithms/models to predict eGFR values and/or classes for patients at certain time point based on entries in claims database (demographic characteristics, clinical diagnoses, procedures and drug treatments) for a general population and a variety of use-cases (AF, CAD, T2DM patients sub-populations).
US OPTUM CDM database, Whippany
Lead Sponsor
Bayer
INDUSTRY